Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aion Therapeutic Inc C.AION

Alternate Symbol(s):  ANTCF

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.


CSE:AION - Post by User

Aion Therapeutic Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(6)
•••
Post by Toronto88on Mar 23, 2021 9:49am
121 Views
Post# 32857258

Patents and Benzinga article

Patents and Benzinga article
https://www.benzinga.com/markets/cannabis/21/03/20263420/these-24-psychedelic-patents-are-paving-the-way-for-medicine-2-0?utm_campaign=Cannabis%20Insider&utm_medium=email&_hsmi=117269819&_hsenc=p2ANqtz-8uOYKCJ09pVHSTqpva_PzADC_B3a6u1YPFwRgTV4Zlx8TWKjyCvzE3dEyVH8-JBFsGtW_dW1jNMEs4JwsD51Zj8XcNeQ&utm_content=117269819&utm_source=hs_email
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities